Citations (59)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (59)
Miles Pourbaghi, Leila Haghani, Ken Zhao, Anita Karimi, Brett Marinelli, Joseph P. Erinjeri, Jean-Francois H. Geschwind & Hooman Yarmohammadi. (2023) Anti-Glycolytic Drugs in the Treatment of Hepatocellular Carcinoma: Systemic and Locoregional Options. Current Oncology 30:7, pages 6609-6622.
Crossref
Crossref
Ana Alfano, Eduardo G. A. Cafferata, Mariela Gangemi, Alejandro Nicola Candia, Cristian M. Malnero, Ismael Bermudez, Mauricio Vargas Lopez, Gregorio David Ríos, Cecilia Rotondaro, Nicasio Cuneo, David T. Curiel, Osvaldo L. Podhajcer & Maria Veronica Lopez. (2023) In Vitro and In Vivo Efficacy of a Stroma-Targeted, Tumor Microenvironment Responsive Oncolytic Adenovirus in Different Preclinical Models of Cancer. International Journal of Molecular Sciences 24:12, pages 9992.
Crossref
Crossref
Xiaoying Jin, Dandan Wang, Mengxia Lei, Yan Guo, Yuqing Cui, Fengzhi Chen, Weiling Sun & Xuesong Chen. (2022) TPI1 activates the PI3K/AKT/mTOR signaling pathway to induce breast cancer progression by stabilizing CDCA5. Journal of Translational Medicine 20:1.
Crossref
Crossref
Amirhosein Naghsh‐Nilchi, Laleh Ebrahimi Ghahnavieh & Fariba Dehghanian. (2022)
Construction of
miRNA‐lncRNA‐mRNA
co‐expression network affecting
EMT‐
mediated cisplatin resistance in ovarian cancer
. Journal of Cellular and Molecular Medicine 26:16, pages 4530-4547.
Crossref
Crossref
Fang Guo, Zhi Yang, Jalid Sehouli & Andreas M. Kaufmann. (2022) Blockade of ALDH in Cisplatin-Resistant Ovarian Cancer Stem Cells In Vitro Synergistically Enhances Chemotherapy-Induced Cell Death. Current Oncology 29:4, pages 2808-2822.
Crossref
Crossref
Yaoqi Sun, Lin Yao, Chunyan Wang, Bing Xiong, Jing Guo, Lian Wang, Jihui Zhu, Zhongping Cheng & Shupeng Liu. (2022) Involvement of Cancer Stem Cells in Chemoresistant Relapse of Epithelial Ovarian Cancer Identified by Transcriptome Analysis. Journal of Oncology 2022, pages 1-16.
Crossref
Crossref
Fabrizio Marcucci & Cristiano Rumio. (2022) Tumor Cell Glycolysis—At the Crossroad of Epithelial–Mesenchymal Transition and Autophagy. Cells 11:6, pages 1041.
Crossref
Crossref
M. Cummings, C. Freer & N.M. Orsi. (2021) Targeting the tumour microenvironment in platinum-resistant ovarian cancer. Seminars in Cancer Biology 77, pages 3-28.
Crossref
Crossref
Min Chen, Juan Su, Chunmei Feng, Ying Liu, Li Zhao & Yongjie Tian. (2021)
Chemokine CCL20 promotes the paclitaxel resistance of CD44
+
CD117
+
cells via the Notch1 signaling pathway in ovarian cancer
. Molecular Medicine Reports 24:3.
Crossref
Crossref
Lauren MacDonagh, Rhyla Mae Santiago, Steven G. Gray, Eamon Breen, Sinead Cuffe, Stephen P. Finn, Kenneth J. O'Byrne & Martin P. Barr. (2021) Exploitation of the vitamin A/retinoic acid axis depletes ALDH1-positive cancer stem cells and re-sensitises resistant non-small cell lung cancer cells to cisplatin. Translational Oncology 14:4, pages 101025.
Crossref
Crossref
Natalia Pieńkowska, Grzegorz Bartosz, Paulina Furdak & Izabela Sadowska-Bartosz. (2021) Delphinidin Increases the Sensitivity of Ovarian Cancer Cell Lines to 3-bromopyruvate. International Journal of Molecular Sciences 22:2, pages 709.
Crossref
Crossref
Maya Petricciuolo, Magdalena Davidescu, Katia Fettucciari, Leonardo Gatticchi, Stefano Brancorsini, Rita Roberti, Lanfranco Corazzi & Lara Macchioni. (2020) The efficacy of the anticancer 3-bromopyruvate is potentiated by antimycin and menadione by unbalancing mitochondrial ROS production and disposal in U118 glioblastoma cells. Heliyon 6:12, pages e05741.
Crossref
Crossref
Francesca D'Este, Emilia Della Pietra, Gretta Veronica Badillo Pazmay, Luigi E. Xodo & Valentina Rapozzi. (2020) Role of nitric oxide in the response to photooxidative stress in prostate cancer cells. Biochemical Pharmacology 182, pages 114205.
Crossref
Crossref
Osama A. Elkashty & Simon D. Tran. (2020) Broccoli extract increases drug-mediated cytotoxicity towards cancer stem cells of head and neck squamous cell carcinoma. British Journal of Cancer 123:9, pages 1395-1403.
Crossref
Crossref
Luca X. Zampieri, Debora Grasso, Caroline Bouzin, Davide Brusa, Rodrigue Rossignol & Pierre Sonveaux. (2020) Mitochondria Participate in Chemoresistance to Cisplatin in Human Ovarian Cancer Cells. Molecular Cancer Research 18:9, pages 1379-1391.
Crossref
Crossref
Louise Flynn, Martin P. Barr, Anne-Marie Baird, Paul Smyth, Orla M. Casey, Gordon Blackshields, John Greene, Stephen R. Pennington, Emily Hams, Padraic G. Fallon, John O’Leary, Orla Sheils & Stephen P. Finn. (2020) Prostate cancer-derived holoclones: a novel and effective model for evaluating cancer stemness. Scientific Reports 10:1.
Crossref
Crossref
Vikas Bhardwaj & Jun He. (2020) Reactive Oxygen Species, Metabolic Plasticity, and Drug Resistance in Cancer. International Journal of Molecular Sciences 21:10, pages 3412.
Crossref
Crossref
Julieta Afonso, Lúcio L. Santos, Adhemar Longatto-Filho & Fátima Baltazar. (2020) Competitive glucose metabolism as a target to boost bladder cancer immunotherapy. Nature Reviews Urology 17:2, pages 77-106.
Crossref
Crossref
Ali F. Abdel-Wahab, Waheed Mahmoud & Randa M. Al-Harizy. (2019) Targeting glucose metabolism to suppress cancer progression: prospective of anti-glycolytic cancer therapy. Pharmacological Research 150, pages 104511.
Crossref
Crossref
Markus Kleih, Kathrin Böpple, Meng Dong, Andrea Gaißler, Simon Heine, Monilola A. Olayioye, Walter E. Aulitzky & Frank Essmann. (2019) Direct impact of cisplatin on mitochondria induces ROS production that dictates cell fate of ovarian cancer cells. Cell Death & Disease 10:11.
Crossref
Crossref
Bezuidenhout & Shoshan. (2019) A Shifty Target: Tumor-Initiating Cells and Their Metabolism. International Journal of Molecular Sciences 20:21, pages 5370.
Crossref
Crossref
Rossina Domínguez-Ríos, Dante R. Sánchez-Ramírez, Kassandra Ruiz-Saray, Paola E. Oceguera-Basurto, Mario Almada, Josué Juárez, Abraham Zepeda-Moreno, Alicia del Toro-Arreola, Antonio Topete & Adrián Daneri-Navarro. (2019) Cisplatin-loaded PLGA nanoparticles for HER2 targeted ovarian cancer therapy. Colloids and Surfaces B: Biointerfaces 178, pages 199-207.
Crossref
Crossref
Alberto Cruz-Bermúdez, Raquel Laza-Briviesca, Ramiro J. Vicente-Blanco, Aránzazu García-Grande, Maria José Coronado, Sara Laine-Menéndez, Sara Palacios-Zambrano, M. Rocío Moreno-Villa, Asunción Martin Ruiz-Valdepeñas, Cristina Lendinez, Atocha Romero, Fernando Franco, Virginia Calvo, Cristina Alfaro, Paloma Martin Acosta, Clara Salas, José Miguel Garcia & Mariano Provencio. (2019) Cisplatin resistance involves a metabolic reprogramming through ROS and PGC-1α in NSCLC which can be overcome by OXPHOS inhibition. Free Radical Biology and Medicine 135, pages 167-181.
Crossref
Crossref
Young H. Ko, Katarzyna Niedźwiecka, Margarida Casal, Peter L. Pedersen & Stanisław Ułaszewski. (2018) 3‐Bromopyruvate as a potent anticancer therapy in honor and memory of the late Professor André Goffeau. Yeast 36:4, pages 211-221.
Crossref
Crossref
Aynaz Mihanfar, Javad Aghazadeh Attari, Iraj Mohebbi, Maryam Majidinia, Mojtaba Kaviani, Mehdi Yousefi & Bahman Yousefi. (2018) Ovarian cancer stem cell: A potential therapeutic target for overcoming multidrug resistance. Journal of Cellular Physiology 234:4, pages 3238-3253.
Crossref
Crossref
Yinu Wang, Xingyue Zong, Sumegha Mitra, Anirban Kumar Mitra, Daniela Matei & Kenneth P. Nephew. (2018) IL-6 mediates platinum-induced enrichment of ovarian cancer stem cells. JCI Insight 3:23.
Crossref
Crossref
Yi Lu, Chujun Li, Honglei Chen & Weijie Zhong. (2018) Identification of hub genes and analysis of prognostic values in pancreatic ductal adenocarcinoma by integrated bioinformatics methods. Molecular Biology Reports 45:6, pages 1799-1807.
Crossref
Crossref
Lauren MacDonagh, Steven G. Gray, Eamon Breen, Sinead Cuffe, Stephen P. Finn, Kenneth J. O'Byrne & Martin P. Barr. (2018) BBI608 inhibits cancer stemness and reverses cisplatin resistance in NSCLC. Cancer Letters 428, pages 117-126.
Crossref
Crossref
Ugo Testa, Eleonora Petrucci, Luca Pasquini, Germana Castelli & Elvira Pelosi. (2018) Ovarian Cancers: Genetic Abnormalities, Tumor Heterogeneity and Progression, Clonal Evolution and Cancer Stem Cells. Medicines 5:1, pages 16.
Crossref
Crossref
Francesca Mastropasqua, Giulia Girolimetti & Maria Shoshan. (2018) PGC1α: Friend or Foe in Cancer?. Genes 9:1, pages 48.
Crossref
Crossref
Do Kim, Tiaosi Xing, Zhibin Yang, Ronald Dudek, Qun Lu & Yan-Hua Chen. (2017) Epithelial Mesenchymal Transition in Embryonic Development, Tissue Repair and Cancer: A Comprehensive Overview. Journal of Clinical Medicine 7:1, pages 1.
Crossref
Crossref
Hiroaki Soyama, Morikazu Miyamoto, Masashi Takano, Tadashi Aoyama, Hiroko Matsuura, Takahiro Sakamoto, Kazuki Takasaki, Mika Kuwahara, Kento Kato, Tomoyuki Yoshikawa, Hideki Iwahashi, Hitoshi Tsuda & Kenichi Furuya. (2017) Ovarian serous carcinomas acquire cisplatin resistance and increased invasion through downregulation of the high-temperature-required protein A2 (HtrA2), following repeated treatment with cisplatin. Medical Oncology 34:12.
Crossref
Crossref
Lauren MacDonagh, Michael F. Gallagher, Brendan Ffrench, Claudia Gasch, Eamon Breen, Steven G. Gray, Siobhan Nicholson, Niamh Leonard, Ronan Ryan, Vincent Young, John J. O’Leary, Sinead Cuffe, Stephen P. Finn, Kenneth J. O’Byrne & Martin P. Barr. (2017) Targeting the cancer stem cell marker, aldehyde dehydrogenase 1, to circumvent cisplatin resistance in NSCLC. Oncotarget 8:42, pages 72544-72563.
Crossref
Crossref
S-L Tung, W-C Huang, F-C Hsu, Z-P Yang, T-H Jang, J-W Chang, C-M Chuang, C-R Lai & L-H Wang. (2017) miRNA-34c-5p inhibits amphiregulin-induced ovarian cancer stemness and drug resistance via downregulation of the AREG-EGFR-ERK pathway. Oncogenesis 6:5, pages e326-e326.
Crossref
Crossref
Bo-Wen Dong, Guang-Ming Qin, Yan Luo & Jian-Shan Mao. (2016) Metabolic enzymes: key modulators of functionality in cancer stem-like cells. Oncotarget 8:8, pages 14251-14267.
Crossref
Crossref
Maria Shoshan. (2017) On mitochondrial metabolism in tumor biology. Current Opinion in Oncology 29:1, pages 48-54.
Crossref
Crossref
Ayako Kanamoto, Itasu Ninomiya, Shinichi Harada, Tomoya Tsukada, Koichi Okamoto, Shinichi Nakanuma, Seisho Sakai, Isamu Makino, Jun Kinoshita, Hironori Hayashi, Katsunobu Oyama, Tomoharu Miyashita, Hidehiro Tajima, Hiroyuki Takamura, Sachio Fushida & Tetsuo Ohta. (2016) Valproic acid inhibits irradiation-induced epithelial-mesenchymal transition and stem cell-like characteristics in esophageal squamous cell carcinoma. International Journal of Oncology.
Crossref
Crossref
Lucie Brisson, Piotr Bański, Martina Sboarina, Coralie Dethier, Pierre Danhier, Marie-Joséphine Fontenille, Vincent F. Van Hée, Thibaut Vazeille, Morgane Tardy, Jorge Falces, Caroline Bouzin, Paolo E. Porporato, Raphaël Frédérick, Carine Michiels, Tamara Copetti & Pierre Sonveaux. (2016) Lactate Dehydrogenase B Controls Lysosome Activity and Autophagy in Cancer. Cancer Cell 30:3, pages 418-431.
Crossref
Crossref
J. Azevedo-Silva, O. Queir?s, F. Baltazar, S. U?aszewski, A. Goffeau, Y. H. Ko, P. L. Pedersen, A. Preto & M. Casal. (2016) The anticancer agent 3-bromopyruvate: a simple but powerful molecule taken from the lab to the bedside. Journal of Bioenergetics and Biomembranes 48:4, pages 349-362.
Crossref
Crossref
Lauren MacDonagh, Steven G. Gray, Eamon Breen, Sinead Cuffe, Stephen P. Finn, Kenneth J. O'Byrne & Martin P. Barr. (2016) Lung cancer stem cells: The root of resistance. Cancer Letters 372:2, pages 147-156.
Crossref
Crossref
Nelson Ho, Jodi Morrison, Andreza Silva & Brenda L. Coomber. (2016) The effect of 3-bromopyruvate on human colorectal cancer cells is dependent on glucose concentration but not hexokinase II expression. Bioscience Reports 36:1.
Crossref
Crossref
Lynn Jeanette Savic, Julius Chapiro, Gregor Duwe & Jean-François Geschwind. (2016) Targeting glucose metabolism in cancer: a new class of agents for loco-regional and systemic therapy of liver cancer and beyond?. Hepatic Oncology 3:1, pages 19-28.
Crossref
Crossref
Y. Wang, F. Fang, S. Condello, D. Matei & K.P. Nephew. 2016. Cancer Stem Cells. Cancer Stem Cells
231
259
.
Verena Rohnalter, Katrin Roth, Florian Finkernagel, Till Adhikary, Julia Obert, Kristina Dorzweiler, Maike Bensberg, Sabine Müller-Brüsselbach & Rolf Müller. (2015) A multi-stage process including transient polyploidization and EMT precedes the emergence of chemoresistent ovarian carcinoma cells with a dedifferentiated and pro-inflammatory secretory phenotype. Oncotarget 6:37, pages 40005-40025.
Crossref
Crossref
E Hedström, C Pederiva, J Farnebo, B Nodin, K Jirström, D J Brennan & M Farnebo. (2015) Downregulation of the cancer susceptibility protein WRAP53β in epithelial ovarian cancer leads to defective DNA repair and poor clinical outcome. Cell Death & Disease 6:10, pages e1892-e1892.
Crossref
Crossref
Chrysi Xintaropoulou, Carol Ward, Alan Wise, Hugh Marston, Arran Turnbull & Simon P. Langdon. (2015) A comparative analysis of inhibitors of the glycolysis pathway in breast and ovarian cancer cell line models. Oncotarget 6:28, pages 25677-25695.
Crossref
Crossref
Ivan Diaz-Padilla, Michelle K. Wilson, Blaise A. Clarke, Hal W. Hirte, Stephen A. Welch, Helen J. Mackay, Jim J. Biagi, Michael Reedijk, Johanne I. Weberpals, Gini F. Fleming, Lisa Wang, Geoffrey Liu, Chen Zhou, Chantale Blattler, S. Percy Ivy & Amit M. Oza. (2015) A phase II study of single-agent RO4929097, a gamma-secretase inhibitor of Notch signaling, in patients with recurrent platinum-resistant epithelial ovarian cancer: A study of the Princess Margaret, Chicago and California phase II consortia. Gynecologic Oncology 137:2, pages 216-222.
Crossref
Crossref
Q H Miow, T Z Tan, J Ye, J A Lau, T Yokomizo, J-P Thiery & S Mori. (2014) Epithelial–mesenchymal status renders differential responses to cisplatin in ovarian cancer. Oncogene 34:15, pages 1899-1907.
Crossref
Crossref
Seiya Sato & Hiroaki Itamochi. (2015) Ovarian Cancer and Drug Resistance. Current Obstetrics and Gynecology Reports 4:1, pages 18-25.
Crossref
Crossref
Mikael KR Engskog, My Björklund, Jakob Haglöf, Torbjörn Arvidsson, Maria Shoshan & Curt Pettersson. (2015) Metabolic profiling of epithelial ovarian cancer cell lines: evaluation of harvesting protocols for profiling using NMR spectroscopy. Bioanalysis 7:2, pages 157-166.
Crossref
Crossref
Loredana Campo, Catherine Zhang & Eun-Kyoung Breuer. (2015) EMT-Inducing Molecular Factors in Gynecological Cancers. BioMed Research International 2015, pages 1-12.
Crossref
Crossref
Francesco Sabbatino, Yangyang Wang, Xinhui Wang, Joseph H. Schwab, Soldano Ferrone & Cristina R. Ferrone. (2014) Novel Tumor Antigen-Specific Monoclonal Antibody-Based Immunotherapy to Eradicate Both Differentiated Cancer Cells and Cancer-Initiating Cells in Solid Tumors. Seminars in Oncology 41:5, pages 685-699.
Crossref
Crossref
Marike Gabrielson, My Björklund, Joseph Carlson & Maria Shoshan. (2014) Expression of Mitochondrial Regulators PGC1α and TFAM as Putative Markers of Subtype and Chemoresistance in Epithelial Ovarian Carcinoma. PLoS ONE 9:9, pages e107109.
Crossref
Crossref
Laura Zinzi, Marialessandra Contino, Mariangela Cantore, Elena Capparelli, Marcello Leopoldo & Nicola A. Colabufo. (2014) ABC transporters in CSCs membranes as a novel target for treating tumor relapse. Frontiers in Pharmacology 5.
Crossref
Crossref
Elizabeth J. Sullivan, Metin Kurtoglu, Randall Brenneman, Huaping Liu & Theodore J. Lampidis. (2013) Targeting cisplatin-resistant human tumor cells with metabolic inhibitors. Cancer Chemotherapy and Pharmacology 73:2, pages 417-427.
Crossref
Crossref
Khalid Abubaker, Ardian Latifi, Rod Luwor, Simon Nazaretian, Hongjian Zhu, Michael A Quinn, Erik W Thompson, Jock K Findlay & Nuzhat Ahmed. (2013) Short-term single treatment of chemotherapy results in the enrichment of ovarian cancer stem cell-like cells leading to an increased tumor burden. Molecular Cancer 12:1.
Crossref
Crossref
Jin Zhou, Pu Li, Xiaofeng Xue, Songbing He, Yuting Kuang, Hong Zhao, Shaoji Chen, Qiaoming Zhi & Xiaobo Guo. (2013) Salinomycin induces apoptosis in cisplatin-resistant colorectal cancer cells by accumulation of reactive oxygen species. Toxicology Letters 222:2, pages 139-145.
Crossref
Crossref
Kashmira Kulkarni-Datar, Sandra Orsulic, Rosemary Foster & Bo R. Rueda. (2013) Ovarian tumor initiating cell populations persist following paclitaxel and carboplatin chemotherapy treatment in vivo. Cancer Letters 339:2, pages 237-246.
Crossref
Crossref
Mi Kwon & Young Shin. (2013) Regulation of Ovarian Cancer Stem Cells or Tumor-Initiating Cells. International Journal of Molecular Sciences 14:4, pages 6624-6648.
Crossref
Crossref